Not yet recruiting NCT07046013

Level of Serum Lactate Dehydrogenase in Immune Thrombocytopenia

— Observational Immune Thrombocytopenia (ITP)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: The protocol lists: Lactate dehydrogenase.
Who it may be relevant to: Registry conditions: Immune Thrombocytopenia (ITP). Basic parameters: from 16 years · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Center list to be confirmed — check the primary protocol.
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Official title

Relation Between Serum Lactate Dehydrogenase and Immune Thrombocytopenia

Assessment of relation between serum lactate dehydrogenase and immune thrombocytopenia

Detailed description

Immune thrombocytopenia is an autoimmune disorder defined by a significantly reduced number of platelets in blood circulation.

Lactate dehydrogenase is a group of oxidoreductase isoenzymes catalyzing the reversible reaction between pyruvate and lactate.

The LDH was found to be moderately high in patients with immune thrombocytopenia at the time of diagnosis.

Diagnostic test Lactate dehydrogenase
It's elevation at the time of diagnosis

Relation between serum lactate dehydrogenase and immune thrombocytopenia [Time frame: About 2 years]

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Center list to be confirmed — check the primary protocol.

NCT: NCT07046013 · Soh-Med-25-5-7MS